ArticleBrain sciences2023

A Real-World Experience of Azathioprine Versus First-Line Disease-Modifying Therapy in Relapsing-Remitting Multiple Sclerosis-A Prospective Cohort Study.

Arpit Agrawal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.